Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 43.60M | £ 55.60M | £ 103.20M | £ 35.70M | £ 111.90M |
Total Assets | £ 1.74B | £ 1.70B | £ 1.71B | £ 1.42B | £ 1.32B |
Total Debt | £ 624.40M | £ 630.30M | £ 681.20M | £ 481.30M | £ 452.80M |
Net Debt | £ 580.80M | £ 574.70M | £ 578.00M | £ 445.60M | £ 340.90M |
Total Liabilities | £ 1.24B | £ 1.22B | £ 1.26B | £ 962.70M | £ 893.10M |
Stockholders Equity | £ 502.50M | £ 483.30M | £ 446.40M | £ 457.90M | £ 431.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |